Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons I. Esen

Publicaties

Impaired IL-6-induced JAK-STAT signaling in CD4+ T cells associates with longer treatment duration in giant cell arteritis

Evidence for increased interferon type I activity in CD8+ T cells in giant cell arteritis patients

Immune signatures in chronic inflammatory diseases: Focus on metabolism and IL-6

Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort

Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits

Comment on: Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in Giant Cell Arteritis: Reply

Humoral and cellular SARS-CoV-2 vaccine responses in patients with giant cell arteritis and polymyalgia rheumatica

Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in Giant Cell Arteritis

Dysregulated Glucose Metabolism and Dyslipidemia in GCA and PMR Patients at Diagnosis

Functionally Heterogenous Macrophage Subsets in the Pathogenesis of Giant Cell Arteritis: Novel Targets for Disease Monitoring and Treatment

Lees meer